In Brief: FDA clinical research conference
This article was originally published in The Gray Sheet
FDA clinical research conference: "Current Issues in Human Subject Protection: An FDA Perspective" is scheduled for Sept. 13 at the Natcher Auditorium on the National Institutes of Health campus in Bethesda, Maryland. FDA personnel will discuss "current regulatory issues," including "the practical applications of the protective mechanisms required by FDA regulations such as the institutional review board (IRB) system and the process of obtaining informed consent," according to an FDA announcement. For information, contact the agency's Office of Health Affairs at 301/827-1685...
You may also be interested in...
Top 100 Review: The Calm Before The Storm – But Some Medtechs Already Reflect The Ravages Of COVID-19
2019 saw fewer revenues-boosting major acquisitions by top-tier medtechs. Companies that reported after the calendar year-end were the first to see the consequences of the pandemic on their annual figures.
Hikma and Sesen Bio have struck a deal that will see Hikma distribute the Vicineum brand in the MENA region.
By establishing a dedicated consumer healthcare subsidiary, Norgine is hoping it can grow its $200m-plus Movicol laxative brand and take advantage of M&A opportunities in the OTC market.